Search Results

The Export Advance™ Aspiration Catheter is indicated for:
• Removal/aspiration of embolic material (thrombus/debris) from vessels of the arterial system, and
• To sub selectively infuse/deliver diagnostics or therapeutics agents with or without vessel occlusion.

Device Description

The Export Advance™ Aspiration Catheter is a dual lumen catheter used for the aspiration of thrombus and/or debris from a vascular site. The Export Advance™ may also be used for the infusion of diagnostic or therapeutic agents to a desired vascular site.

AI/ML Overview

The provided text describes a 510(k) premarket notification for the Medtronic Export Advance™ Aspiration Catheter, which is a medical device and not an AI/ML product. Therefore, the requested information regarding acceptance criteria and studies for an AI device is not available in the given document.

The document discusses Design Verification (bench) testing and Biocompatibility testing for the catheter, emphasizing that no clinical investigation was performed on this specific device iteration. The goal was to demonstrate substantial equivalence to a predicate device, not to prove the performance of an AI model against specific acceptance criteria.

Below is a summary of the available information regarding the device's assessment, structured to align with your request where applicable, but noting the absence of AI-specific details:

Device: Medtronic Export Advance™ Aspiration Catheter

Type of Device: Embolectomy Catheter (Class II)

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria Category	Specific Tests Performed	Reported Device Performance / Conclusion
Design Verification (Bench Testing)	1. Profile Dimensions (Major & Minor Profile)	Met acceptance criteria and showed performance similar to the predicate device. Only attributes impacted by the dual lumen section change were tested.
	2. Microlumen Tear
	3. 2D Track and Lesion Cross	(Specific results not detailed, but stated to have met acceptance criteria)
Biocompatibility Testing	1. Cytotoxicity	Concluded full biocompatibility, based on existing data for the predicate device and the fact that the material change (microlumen sleeve from Pebax 4033 to Aesno MED Nylon 12 (AV100)) is already in use on the Export Advance and cuff extension. No additional testing was required.
	2. In vitro Hemolysis
	3. Systemic Toxicity
	4. Sensitization
	5. C3a Complement Activation
	6. Sc5b9 Complement Activation
	7. ISO Intracutaneous Reactivity
	8. USP Material Mediated Pyrogen Study
	9. In vivo Thromboresistance
Overall Conclusion	Substantial Equivalence to Predicate Device	No new safety or effectiveness issues were raised during testing. The bench testing qualification and biocompatibility testing demonstrated that the subject device is substantially equivalent to the predicate device.

Since this document pertains to a physical medical device (catheter) and not an AI/ML product, the subsequent points (2-9) which are specific to AI/ML model evaluations cannot be answered from the provided text.

Specifically:

2. Sample size used for the test set and the data provenance: Not applicable; no AI test set.
3. Number of experts used to establish the ground truth... and qualifications: Not applicable; no AI ground truth establishment.
4. Adjudication method: Not applicable.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done...: Not applicable; no AI assistance involved.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: Not applicable; no AI algorithm.
7. The type of ground truth used: Not applicable; no AI ground truth. The "ground truth" for a physical device is its physical performance and material properties.
8. The sample size for the training set: Not applicable; no AI training set.
9. How the ground truth for the training set was established: Not applicable; no AI training set.

Ask a Question

Ask a specific question about this device

Page 1 of 1